Shanghai Henlius Biotech, Inc. (2696.HK)

HKD 40.35

(3.59%)

Gross Profit Summary of Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc.'s latest annual gross profit in 2023 was 3.91 Billion CNY , up 65.34% from previous year.
Shanghai Henlius Biotech, Inc.'s latest quarterly gross profit in 2024 Q2 was 995.34 Million CNY , down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported a annual gross profit of 2.37 Billion CNY in annual gross profit 2022, up 104.37% from previous year.
Shanghai Henlius Biotech, Inc. reported a annual gross profit of 1.15 Billion CNY in annual gross profit 2021, up 186.02% from previous year.
Shanghai Henlius Biotech, Inc. reported a quarterly gross profit of 995.34 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported a quarterly gross profit of 3.91 Billion CNY for 2023 FY, up 65.34% from previous quarter.

Annual Gross Profit Chart of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Historical Annual Gross Profit of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Year	Gross Profit	Gross Profit Growth
2023	3.91 Billion CNY	65.34%
2022	2.37 Billion CNY	104.37%
2021	1.15 Billion CNY	186.02%
2020	405.46 Million CNY	2021.98%
2019	19.1 Million CNY	844.54%
2018	2.02 Million CNY	-89.29%
2017	18.89 Million CNY	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	995.34 Million CNY	-11.09%
2024 Q2	995.34 Million CNY	0.0%
2023 FY	3.91 Billion CNY	65.34%
2023 Q1	889.41 Million CNY	18.5%
2023 Q4	1.11 Billion CNY	9.71%
2023 Q3	1.02 Billion CNY	14.73%
2023 Q2	889.41 Million CNY	0.0%
2022 Q4	750.56 Million CNY	18.06%
2022 Q3	635.75 Million CNY	29.25%
2022 Q2	491.89 Million CNY	0.0%
2022 Q1	491.89 Million CNY	31.6%
2022 FY	2.37 Billion CNY	104.37%
2021 Q3	373.77 Million CNY	81.36%
2021 Q2	206.08 Million CNY	0.0%
2021 Q1	206.08 Million CNY	16.62%
2021 FY	1.15 Billion CNY	186.02%
2021 Q4	373.77 Million CNY	0.0%
2020 FY	405.46 Million CNY	2021.98%
2020 Q4	176.72 Million CNY	0.0%
2020 Q2	26.01 Million CNY	0.0%
2020 Q1	26.01 Million CNY	289.26%
2020 Q3	176.72 Million CNY	579.37%
2019 Q4	6.68 Million CNY	0.0%
2019 Q2	4.81 Million CNY	421.54%
2019 Q1	924 Thousand CNY	-8.65%
2019 FY	19.1 Million CNY	844.54%
2019 Q3	6.68 Million CNY	38.67%
2018 Q4	1.01 Million CNY	0.0%
2018 FY	2.02 Million CNY	-89.29%
2018 Q3	1.01 Million CNY	0.0%
2018 Q2	- CNY	0.0%
2018 Q1	- CNY	0.0%
2017 FY	18.89 Million CNY	0.0%

Peer Gross Profit Comparison of Shanghai Henlius Biotech, Inc.

Name	Gross Profit	Gross Profit Difference
Uni-Bio Science Group Limited	392.81 Million HKD	-897.611%
CK Life Sciences Int'l., (Holdings) Inc.	947.7 Million HKD	-313.503%